PRODUCT DATASHEET · DC67463
CP-LC-1428
Version 1.1613dd69 · 2026-09-13
| CAS No. | Not available |
| Chemical Name | CP-LC-1428 |
| Synonyms | 6-methylheptyl 7-(2-((3-((2-butyloctyl)oxy)-3-oxopropyl)thio)ethyl)-2-methyl-14-((3-((6-methylheptyl)oxy)-3-oxopropyl)thio)-6,9-dioxo-17-thia-2,5,8-triazaicosan-20-oate,CPLC1428， CP LC 1428 |
| SMILES | O=C(NCCN(C)C)C(CCSCCC(OCC(CCCC)CCCCCC)=O)NC(CCCCC(CCSCCC(OCCCCCC(C)C)=O)SCCC(OCCCCCC(C)C)=O)=O |
| Formula | C53H101N3O8S3 |
| M.Wt | 1,004.6 |
| Purity | >98% |
| Storage | Original product: up to 1 year under the storage conditions stated on the vial, kept tightly sealed. Stock solutions: aliquots at -20°C, generally up to one month. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
Derived from the natural amino acid homocysteine, CP-LC-1428 is an ionizable cationic lipid that enables highly efficient in vivo delivery of multiple RNA formats (including mRNA, cRNA and saRNA) with robust protein expression. When formulated into standard LNPs (50:38.5:10:1.5 molar ratio of ionizable lipid:cholesterol:DOPE:PEG-lipid), it demonstrates superior spleen-selective targeting compared to conventional delivery systems following intravenous administration, while maintaining an excellent safety profile.
Specifications shown are product-page values, not batch test results.
Read Instructions for Use →